Suppr超能文献

一种强效特异性拮抗剂[1-(β-巯基-β,β-环戊亚甲基丙酸)2-(O-甲基)酪氨酸]精氨酸加压素对加压素升压反应的长期抑制作用。

Prolonged inhibition of pressor response to vasopressin by a potent specific antagonist, [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid) 2-(O-methyl)tyrosine]arginine-vasopressin.

作者信息

Pang C C, Leighton K M

出版信息

Can J Physiol Pharmacol. 1981 Sep;59(9):1008-12. doi: 10.1139/y81-153.

Abstract

The specificity, the potency, and the duration of action of [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid) 2-(O-methyl)tyrosine]arginine-vasopressin[d(CH2)5Tyr(Me)AVP] to antagonize pressor responses to arginine vasopressin (AVP) was examined in pentobarbital-anaesthetized rats. Injection of the compound (4 micrograms.kg-1 i.v.) prevented pressor responses to i.v. infusions of supramaximal doses of AVP, but not to i.v. infusions of another peptide, angiotensin II (Ag II). The antagonism of AVP persisted for at least 3 h. Since i.v. injection of the compound in the absence of exogenous administration of AVP did not cause any change in the arterial pressure of rats, it appears that the compound is devoid of agonistic pressor activity. The results show that d(CH2)5Tyr(Me)AVP is a potent and a specific antagonist of pressor responses to AVP.

摘要

在戊巴比妥麻醉的大鼠中,研究了[1-(β-巯基-β,β-环五亚甲基丙酸)2-(O-甲基)酪氨酸]精氨酸加压素[d(CH2)5Tyr(Me)AVP]拮抗精氨酸加压素(AVP)升压反应的特异性、效价和作用持续时间。静脉注射该化合物(4微克·千克-1)可预防对静脉输注超最大剂量AVP的升压反应,但对静脉输注另一种肽血管紧张素II(Ag II)的升压反应无效。对AVP的拮抗作用持续至少3小时。由于在没有外源性给予AVP的情况下静脉注射该化合物不会引起大鼠动脉血压的任何变化,因此该化合物似乎没有激动性升压活性。结果表明,d(CH2)5Tyr(Me)AVP是AVP升压反应的一种强效且特异性拮抗剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验